People diagnosed with borderline personality disorder should get written information on psychiatric drugs prescribed to them, mental health professionals have been told.
Such information should include evidence for the drug’s effectiveness and harm, say new clinical guidelines issued by the National Institute for Health and Clinical Excellence (NICE).
Patients should be allowed to discuss the information, so they can make an informed choice, say the guidelines.
NICE has this week also released new guidelines for the treatment of anti-social personality disorder. NICE says almost 50% of prisoners have this diagnosis.
Both guidelines discuss psychological and pharmacological interventions for the disorders.
Advice on dangerous and severe personality disorder and child conduct disorders is included in the anti-social personality disorder guidelines.
The Association of Therapeutic Communities criticised the guidlines for “underplaying” the value of therapeutic communities.
It said therapeutic communities, such as the Cassel Hospital in Richmond, Surrey, having been successfully treating people diagnosed with personality disorders for the last 60 years.